GlassScriptPhysician profile
Jerry L Powell
NPI 1669405536
$1,380.84
in general payments reported to CMS, 2019-2025
10 companies · $85.20 in 2025
The $85.20 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $24.95 · 2021: $354 · 2022: $341 · 2023: $145 · 2024: $59.76 · 2025: $85.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $702.82 | 2019-2024 | |
| Pfizer INC. | $290.69 | 2019-2025 | |
| Gilead Sciences, INC. | $99.93 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $96.79 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.86 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $29.04 | 2020-2024 | Zerbaxa, Dificid, Recarbrio |
| Sunovion Pharmaceuticals INC. | $28.37 | 2019 | |
| Lundbeck LLC | $24.32 | 2019 | |
| Philips North America LLC | $14.29 | 2022 | |
| Boston Scientific Corporation | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.